Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2024
4 years of board service in total across 2 boards, counting each seat separately. Longest: Dermata Therapeutics Inc., 2 years.
Dermata Therapeutics Inc.
Director
Cytokinetics Incorporated
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cytokinetics Incorporated May 27, 202679.2%
-
Dermata Therapeutics Inc. May 7, 202498.7%
-
Cytokinetics Incorporated May 10, 202391.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 2026 | Cytokinetics Incorporated | Grant or award | +75 | $82.62 | $6,197 |
| May 27, 2026 | Cytokinetics Incorporated | Grant or award | +2,851 | — | — |
| May 5, 2026 | Cytokinetics Incorporated | Option exercise | +4,032 | $12.40 | $49,997 |
| May 5, 2026 | Cytokinetics Incorporated | Open-market sale | −4,032 | $75.00 | $302,400 |
| Apr 15, 2026 | Cytokinetics Incorporated | Grant or award | +95 | $65.37 | $6,210 |
| Jan 15, 2026 | Cytokinetics Incorporated | Grant or award | +98 | $63.44 | $6,217 |
| Dec 22, 2025 | Cytokinetics Incorporated | Option exercise | +20,000 | $7.61 | $152,200 |
| Dec 22, 2025 | Cytokinetics Incorporated | Open-market sale | −20,000 | $66.14 | $1,322,800 |
| Oct 27, 2025 | Cytokinetics Incorporated | Option exercise | +4,375 | $10.00 | $43,750 |
| Oct 27, 2025 | Cytokinetics Incorporated | Open-market sale | −4,375 | $58.68 | $256,725 |
| Oct 15, 2025 | Cytokinetics Incorporated | Grant or award | +99 | $62.80 | $6,217 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.